| 期刊全稱 | Anticancer Plants: Clinical Trials and Nanotechnology | | 期刊簡稱 | Volume 3 | | 影響因子2023 | Mohd Sayeed Akhtar,Mallappa Kumara Swamy | | 視頻video | http://file.papertrans.cn/159/158491/158491.mp4 | | 發(fā)行地址 | Describes the basis of isolated bioactive anticancer compounds from anticancer plants.Elaborates on the use of recent molecular techniques for cancer cell detection and treatment.Provides an overview | | 圖書封面 |  | | 影響因子 | .Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer..Plants such as?.Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus.?etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol,?.podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine?.etc. have been isolated and purified from these medicinal plants..Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using p | | Pindex | Book 2017 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-23 23:17
發(fā)表于 2025-3-21 19:49:15
